title: Review article: Venous thromboembolism after total joint replacement.
abstract: Venous thromboembolism can occur in up to 84% of cases following total joint replacement. It can result in pain, swelling, chronic post-thrombotic syndrome, and pulmonary embolism. Its prevention is vital to the success of the surgery. To achieve a safe and effective prophylaxis, a combination of mechanical and pharmacologic agents should be used. New generation of thromboprophylactic agents target different factors of the coagulation pathway.
authors.affiliation: Department of Orthopaedics and Traumatology, Queen Mary Hospital, Hong Kong.
authors.forename: K H
authors.initials: KH
authors.lastname: Leung
authors.forename: K Y
authors.initials: KY
authors.lastname: Chiu
authors.forename: C H
authors.initials: CH
authors.lastname: Yan
authors.forename: F Y
authors.initials: FY
authors.lastname: Ng
authors.forename: P K
authors.initials: PK
authors.lastname: Chan
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D019643:Arthroplasty, Replacement / Q000009:adverse effects*; D014943:Global Health; D006801:Humans; D015994:Incidence; D011183:Postoperative Complications; D054556:Venous Thromboembolism / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control
chemical_list: D000925:Anticoagulants
keywords: arthroplasty,
  replacement, knee; arthroplasty, replacement, hip; postthrombotic syndrome; pulmonary embolism; venous thromboembolism